The Valley Desk

NCT01103635 · Interventional trial

Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma

Overall registry status Completed

Phase 1

Conditions Recurrent Melanoma, Stage IV Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov